Population pharmacokinetics and dosing regimen design of milrinone in preterm infants
M Paradisis, X Jiang, AJ McLachlan, N Evans… - Archives of Disease in …, 2007 - fn.bmj.com
Aims: To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
[PDF][PDF] Population pharmacokinetics and dosing regimen design of milrinone in preterm infants
M Paradisis, X Jiang, AJ McLachlan, N Evans… - Arch Dis Child Fetal …, 2007 - Citeseer
Aims: To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
[PDF][PDF] Population pharmacokinetics and dosing regimen design of milrinone in preterm infants
M Paradisis, X Jiang, AJ McLachlan… - Arch Dis Child Fetal …, 2007 - researchgate.net
Aims: To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
[PDF][PDF] Population pharmacokinetics and dosing regimen design of milrinone in preterm infants
M Paradisis, X Jiang, AJ McLachlan… - Arch Dis Child Fetal …, 2007 - academia.edu
Aims: To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
Population pharmacokinetics and dosing regimen design of milrinone in preterm infants
M Paradisis, X Jiang, AJ McLachlan, N Evans… - Archives of Disease in …, 2006 - fn.bmj.com
Aims: To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 hours after birth …
optimal dose regimen to prevent low systemic blood flow in the first 12 hours after birth …
[HTML][HTML] Population pharmacokinetics and dosing regimen design of milrinone in preterm infants
M Paradisis, X Jiang, AJ McLachlan… - Archives of Disease …, 2007 - ncbi.nlm.nih.gov
Aims To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
Population pharmacokinetics and dosing regimen design of milrinone in preterm infants
M Paradisis, X Jiang, AJ McLachlan… - … of disease in …, 2007 - pubmed.ncbi.nlm.nih.gov
Aims To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
Population pharmacokinetics and dosing regimen design of milrinone in preterm infants
M Paradisis, X Jiang, AJ McLachlan… - Archives of Disease …, 2007 - search.proquest.com
Aims: To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
Population pharmacokinetics and dosing regimen design of milrinone in preterm infants.
M Paradisis, X Jiang, AJ McLachlan… - Archives of Disease …, 2006 - europepmc.org
Aims To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
Population pharmacokinetics and dosing regimen design of milrinone in preterm infants.
M Paradisis, X Jiang, AJ McLachlan… - Archives of Disease …, 2006 - europepmc.org
Aims To define the pharmacokinetics of milrinone in very preterm infants and determine an
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …
optimal dose regimen to prevent low systemic blood flow in the first 12 h after birth. Methods …